The incidences and mortalities of major cancers in China, 2010

To estimate the cancer incidences and mortalities in China in 2010, the National Central Cancer Registry （NCCR） of China evaluated data for the year of 2010 from 145 qualified cancer registries covering 158,403,248 people （92,433,739 in urban areas and 65,969,509 in rural areas）. The estimates of new cancer cases and cancer deaths were 3,093,039 and 1,956,622 in 2010, respectively. The percentage of morphologically verified cases were 67.11%; 2.99% of incident cases were identified through death certification only, with the mortality to incidence ratio of 0.61. The crude incidence was 235.23/100,000 （268.65/100,000 in males and 200.21/100,000 in females）. The age-standardized rates by Chinese standard population （ASR China） and by world standard population （ASR world） were 184.58/100,000 and 181.49/100,000, respectively, with a cumulative incidence （0-74 years old） of 21.11%. The crude cancer mortality was 148.81/100,000 （186.37/100,000 in males and 109.42/100,000 in females）. The ASR China and ASR world were 113.92/100,000 and 112.86/100,000, respectively, with a cumulative mortality of 12.78%. Lung, breast, gastric, liver, esophageal, colorectal, and cervical cancers were the most common cancers. Lung, liver, gastric, esophageal, colorectal, breast, and pancreatic cancers were the leading causes of cancer deaths. The coverage of cancer registration has rapidly increased in China in recent years and may reflect more accurate cancer burdens among populations living in different areas. Given the increasing cancer burden in the past decades, China should strengthen its cancer prevention and control.     

2016年江苏省恶性肿瘤流行情况分析

目的 估算江苏省2016年恶性肿瘤发病和死亡情况,分析其流行特征。方法 利用2019年江苏省疾病预防控制中心收集并审核通过的41个肿瘤登记处的2016年资料,分别计算各癌种分城乡、性别和年龄组的发病率和死亡率;结合2016年全省相应分组的户籍人口数据,推算全省恶性肿瘤的发病数和死亡数,并计算对应的发病(死亡)率、中国人口标化率(中标率)、世界人口标化率(世标率)、0~74岁累积发病(死亡)率和前10位恶性肿瘤发病(死亡)顺位等指标。标准人口采用2000年中国普查标准人口构成和Segi's世界标准人口。结果 估计2016年全省新发恶性肿瘤病例25.41万例,发病率为327.48/10万,中标率为182.61/10万,世标率为178.85/10万,0~74岁累积发病率为20.98%。肺癌、胃癌、食管癌、结直肠癌、肝癌和女性乳腺癌是江苏省常见恶性肿瘤。全省估计因恶性肿瘤死亡病例16.87万例,死亡率为217.44/10万,中标率为109.30/10万,世标率为107.94/10万,0~74岁累积死亡率为12.15%。肺癌、胃癌、食管癌、肝癌和结直肠癌是江苏省主要的恶性肿瘤死因。江苏省超过81%的恶性肿瘤发病和91%以上的恶性肿瘤死亡均发生在50岁及以上人群,特别是60岁及以上老年人。结论 江苏省恶性肿瘤疾病负担不断升高,呈现发展中国家癌谱和发达国家癌谱共存的复杂局面。应针对不同地区和不同癌种,在高危人群采取综合防控措施,降低恶性肿瘤死亡率。     

中国2010年胃癌发病与死亡分析

[目的]分析2010年全国肿瘤登记地区胃癌的发病与死亡情况。[方法]对全国219个肿瘤登记处上报的2010年肿瘤登记数据进行评估,共145个登记处的数据入选,计算胃癌的发病率、死亡率、构成、累积率等。人口标准化率以全国2000年人口普查的人口结构和Segi’s世界人口结构为标准。[结果]2010年145个登记处覆盖人口158 403 248人（其中城市人口92 433 739人,农村人口65 969 509人）,胃癌新发病例51 897例,死亡病例37 514例。全国胃癌发病率为30.77/10万（男性42.77/10万,女性18.18/10万）,中标率为23.71/10万,世标率为23.68/10万,累积率（0~74岁）为2.95%。城市地区发病率为29.24/10万,中标率为20.72/10万;农村地区发病率为32.32/10万,中标率为27.37/10万。全国胃癌死亡率为21.89/10万（男性29.72/10万,女性13.68/10万）,中标率为16.64/10万,世标率为16.53/10万,累积死亡率（0~74岁）为1.96%。城市地区死亡率为20.36/10万,中标率为14.09/10万;农村地区死亡率为23.45/10万,中标率为19.82/10万。[结论]胃癌是威胁我国居民健康的主要癌症之一,其在男女性和城乡之间存在明显差异,应根据实际情况有重点地开展防治工作。     

2009～2012年湖南省肿瘤登记地区口腔癌

[目的]分析2009～2012年湖南省肿瘤登记地区居民口腔癌的发病、死亡情况,为该地区口腔癌防治提供基础信息.[方法]收集湖南省肿瘤登记地区2009～2012年口腔癌发病、死亡数据,计算口腔癌的发病率、死亡率、顺位、0～74岁累积率等指标,中标率的标准人口采用2000年全国人口普查的人口构成,世标率的标准人口使用的是Segi's世界人口构成.[结果] 2009～2012年湖南省6个肿瘤登记点共收集口腔癌新发病例297例(其中男性226例,女性71例),死亡病例108例(其中男性90例,女性18例).病理诊断率89.90％,只有死亡医学证明书比例0.67％,死亡,发病比为0.36.全省口腔癌发病率2.94/10万,中标率为2.36/10万,世标率2.27/10万,0～74岁累积率为0.25％.男性口腔癌发病率是4.33/10万,女性为1.45/10万,粗发病率和标化率男性均高于女性.城市地区口腔癌发病率是3.85/10万,而农村为2.58/10万,粗发病率和标化率城区均高于农村.2009～2012年湖南省肿瘤登记地区居民口腔癌死亡率为1.07/10万,死亡中标率为0.81/10万,死亡世标率0.79/10万,0～74岁累积率为0.09％.城市地区口腔癌死亡率是1.12/10万,农村为1.05/10万,死亡粗率和标化率城区均高于农村.男性口腔癌死亡率是1.72/10万,女性为0.37/10万,死亡粗率和标化率男性高于女性.[结论]口腔癌是威胁湖南省40岁以上男性居民身体健康的恶性肿瘤之一,这部分人群应注意采取口腔癌的预防措施.     

Ovary cancer incidence and mortality in China, 2011

Objective

To evaluate and analyze ovary cancer incidence and mortality in China in 2011 using ovary cancer data from population-based cancer registration in China, and to provide scientific information for its control and prevention.

Methods

Invasive cases of ovary cancer were extracted and analyzed from the overall Chinese cancer database in 2011, which were based on data from 177 population-based cancer registries distributing in 28 provinces. The crude, standardized, and truncated incidences and mortalities et al. were calculated and new and deaths cases from ovary cancer throughout China and in different regions in 2011 were estimated using Chinese practical population.

Results

The estimates of new ovary cancer cases and deaths were 45,223 and 18,430, respectively, in China in 2011. The crude incidence rate, age-standardized rate by Chinese standard population (ASR-C) and age-standardized rate by world standard population (ASR-W) incidence were 6.89/100,000, 5.35/100,000 and 5.08/100,000, respectively; the crude, ASR-C and ASR-W mortalities were 2.81/100,000, 2.01/100,000 and 1.99/100,000, respectively. The incidence and mortality in urban areas were higher than those in rural areas. The age-specific incidence and mortality increased rapidly from age 35-39 and peaked at age 60-64 or 75-79 years. After age 45 or 55, the age-specific incidence and death rates in urban were much higher than those in rural areas.

Conclusions

Compared with GLOBOCAN 2012 data, the ovary cancer incidence in China in 2011 was at middle level, but its mortality was at low level worldwide.     

The incidences and mortalities of major cancers in China, 2009

In 2012, the National Central Cancer Registry (NCCR) of China collected cancer registration information for the year 2009 from local cancer registries and analyzed it to describe the incidences and mortalities of cancers in China. Based on the data quality criteria from NCCR, data from 104 registries covering 85,470,522 people (57,489,009 in urban areas and 27,981,513 in rural areas) were checked and evaluated. The data from 72 registries were qualified and accepted for the cancer registry annual report in 2012. The total cancer incident cases and cancer deaths were 244,366 and 154,310, respectively. The morphologically verified cases accounted for 67.23%, and 3.14% of the incident cases only had information from death certifications. The crude incidence in the Chinese cancer registration areas was 285.91/ 100,000 (317.97/100,000 in males and 253.09/100,000 in females). The age-standardized rates for incidences based on the Chinese standard population (ASRIC) and the world standard population (ASRIW) were 146.87/100,000 and 191.72/100,000, respectively, with a cumulative incidence of 22.08%. The cancer mortality in the Chinese cancer registration areas was 180.54/100,000 (224.20/100,000 in males and 135.85/100,000 in females). The age-standardized rates for mortalities based on the Chinese standard population (ASRMC) and the world standard population (ASRMW) were 85.06/100,000 and 115.65/100,000, respectively, and the cumulative mortality was 12.94% . Lung cancer, gastric cancer, colorectal cancer, liver cancer, esophageal cancer, pancreatic cancer, encephaloma, lymphoma, female breast cancer, and cervical cancer were the most common cancers, accounting for 75% of all cancer cases. Lung cancer, gastric cancer, liver cancer, esophageal cancer, colorectal cancer, pancreatic cancer, breast cancer, encephaloma, leukemia, and lymphoma accounted for 80% of all cancer deaths. The cancer registration's population coverage has been increasing, and its data quality is improving. As the basis of the cancer control program, the cancer registry plays an important role in directing anticancer strategies in the medium and long term. Because cancer burdens are different in urban and rural areas in China, prevention and control efforts should be based on practical situations.     

2012年湖北省肿瘤登记地区恶性肿瘤发病与死亡情况分析

目的 分析湖北省肿瘤登记地区2012年恶性肿瘤的发病与死亡流行特征。方法 收集整理2012年湖北省肿瘤登记地区上报的恶性肿瘤发病与死亡数据,计算发病/死亡粗率、年龄别发病（死亡）率,0~74累积率等指标。结果 2012年湖北省肿瘤登记地区覆盖人口数为8 221 036人（其中男性4 183 884人,女性4 037 152人）。新发病例数24 182例,发病粗率为294.15/10万（男性319.92/10万,女性267.44/10万）,中国人口标化率（用2000年中国人口）为194.33/10万,世界人口标化率为210.93/10万。恶性肿瘤死亡病例14 459例,死亡粗率为175.88/10万 ,中标率是111.20/10万,世标率125.76/10万。湖北省肿瘤登记地区的恶性肿瘤发病首位为肺癌,其次为乳腺癌、肝癌、结直肠癌、胃癌、子宫颈癌、食管癌、甲状腺癌、前列腺癌和卵巢癌。占全部恶性肿瘤发病的74.35%。恶性肿瘤死亡前十位分别为肺癌、肝癌、胃癌、结直肠癌、乳腺癌、食管癌、胰腺癌、淋巴瘤、子宫颈癌及前列腺癌。占全部恶性肿瘤死亡的81.05%。结论 湖北省肿瘤登记地区发病主要癌种为肺癌、乳腺癌、消化系统肿瘤。湖北肿瘤登记城市地区甲状腺癌发病率较高需引起重视。     

Nasopharyngeal carcinoma incidence and mortality in China in 2010

Nasopharyngeal carcinoma （NPC） is common in South China. Although regional epidemiological data on NPC in China is available, national epidemiological data have been unavailable up to now. The goal of this study was to analyze the NPC incidence and mortality data in some domestic cancer registries, estimate these rates in China in 2010, and provide scientific information that can be harnessed for NPC control and prevention. To accomplish this goal, NPC incidence and mortality data for 2010 were collected from 145 Chinese cancer registries from which data were included in the 2013 National Cancer Registry Annual Report. Such indices as its incident and death numbers, crude rates, age-standardized rates and truncated rates were calculated and analyzed. The incidence and mortality in China and constituent areas were estimated according to the national population in 2010. An estimated 41,503 new cases and 20,058 deaths were attributed to NPC in China in 2010, accounting for 1.34% of all new cancer cases and 1.03% of all cancer-related deaths that year in China. Crude incidence and mortality were 3.16/100,000 and 1.53/100,000, respectively. World age-standardized incidence and mortality were 2.44/100,000 and 1.18/100,000, respectively. Incidence and mortality were higher among males than among females and slightly higher in urban areas than in rural areas. Among seven Chinese administrative regions, NPC incidence and mortality were obviously higher in South China than in other regions and lowest in North China. The male and female age-specific incidence and mortality both rose quickly from age 25-29 years, but peaked at different ages and varied by location. These results demonstrated that NPC incidence and mortality in China especially in South China were at high levels in the world, and suggested that control and prevention efforts should be enhanced.     

2009—2015年甘肃省肿瘤登记地区肝癌流行特征及变化趋势分析

目的分析甘肃省肿瘤登记地区2009—2015年肝癌发病和死亡流行特征,为制定肝癌防治策略提供依据。方法按照全国肿瘤登记中心制定的审核方法收集甘肃省10个肿瘤登记点上报的数据作为样本数据,描述甘肃省肝癌发病和死亡分布情况,按地区(城市/农村)、性别、年龄进行分层,计算肝癌发病与死亡粗率、中国人口标化率(简称中标率)、世界人口标化率(简称世标率)、累积率,以及发病和死亡的时间变化趋势。结果2009—2015年甘肃省肿瘤登记地区肝癌新发病例7457例,粗发病率为19.63/10万,中标率为17.36/10万,世标率为19.56/10万,居全部恶性肿瘤发病顺位第3位;死亡病例3279例,粗死亡率为16.48/10万,中标率为15.04/10万,世标率为17.36/10万,居全部恶性肿瘤死亡顺位第4位。肝癌发病率和死亡率均随年龄增长而上升,在85+年龄组达到高峰,呈现农村高于城市、男性高于女性的特点。甘肃省2009—2015年肝癌发病率呈上升趋势,APC为2.5%(t=1.0,P=0.4);死亡率呈下降趋势,APC为-3.7%(t=-1.1,P=0.3)。结论甘肃省肿瘤登记地区肝癌发病率呈上升趋势,而死亡率呈下降趋势,农村地区和男性人群是重点干预对象。     

2017年福建省肿瘤登记地区肝癌发病和死亡分析

目的分析2017年福建省肿瘤登记地区肝癌发病和死亡数据,为肝癌防治策略制定和评估提供科学依据。方法根据全国肿瘤登记中心制定的数据审核和评价方法,对福建省12个肿瘤登记处上报的2017年数据进行评价,将符合要求的10个登记处数据合并分析。按城乡、性别和年龄组分别计算肝癌发病和死亡粗率、标化率、累积率(0~74岁)。中国人口标化率(简称中标率)根据2000年中国标准人口构成计算,世界人口标化率(简称世标率)按照Segi′s标准人口构成计算。结果2017年福建省10个肿瘤登记处共覆盖登记人口6588959人,城市地区占43.89%,农村地区占56.11%。2017年福建省肿瘤登记地区肝癌发病率为31.14/10万(男性48.02/10万,女性13.70/10万),中标率为22.51/10万,世标率为21.70/10万。农村地区发病率(中标率23.87/10万,世标率22.90/10万)高于城市地区(中标率20.81/10万,世标率20.16/10万)。2017年福建省肿瘤登记地区肝癌死亡率为28.09/10万(男性43.78/10万,女性11.88/10万),中标率为20.04/10万,世标率为19.45/10万。农村地区死亡率(中标率20.91/10万,世标率20.18/10万)高于城市地区(中标率18.99/10万,世标率18.56/10万)。结论福建省肝癌流行呈现地区和性别差异,应从一级预防和二级预防方面开展针对性防控工作。     

中国2010年恶性肿瘤发病与死亡

[目的]评估我国2010年恶性肿瘤的发病与死亡情况。[方法]按照全国肿瘤登记中心制定的审核方法和评价标准对全国219个登记处上报的2010年肿瘤登记数据进行评估．共145个肿瘤登记处的数据入选登记年报,将入选的登记处按城乡、地区（东、中、西）、性别分层,计算各层年龄别肿瘤别发病率和死亡率,然后根据全国实际人口,估计全国恶性肿瘤合计和主要肿瘤的发病、死亡情况。标准人口按照全国2000年人口普查人口结构和Segi’S世界人口结构为标准计算调整率。[结果]2010年人选年报的145个登记处（城市63个,农村82个）,共覆盖人群158403248人（其中城市92433739人,农村65969509人）,病理诊断比例为67．11％。只有死亡证明书比例为2．99％,死亡／发病比为0．61。估计全国2010年新发恶性肿瘤病例约3093039例,死亡病例1956622例。全国恶性肿瘤发病率为235．23／10万（男性268．65／10万．女性200．21／10万）,中国人口标化率（中标率）184．58／10万,世界人口标化率（世标率）181．49／10万,累积率（0—74岁）为21．11％。城市地区发病率为256．41／10万,中标发病率187．53／10万：农村地区发病率为213．71／10万,中标发病率181．10／10万。全部地区恶性肿瘤死亡率为148．81／10万（男性186．37／10万,女性109．42／10万）,中标死亡率113．92／10万,世标死亡率112．86／10万,累积死亡率（0～74岁）为12．78％。城市地区死亡率为156．14／10万,中标死亡率109．21／10万。农村地区肿瘤死亡率为141．35／10万,中标死亡率119．00／10万。肺癌、女性乳腺癌、胃癌、肝癌、食管癌、结直肠癌和宫颈癌是我国主要的常见的恶性肿瘤。肺癌、肝癌、胃癌、食管癌、结直肠癌、女性乳腺癌和胰腺癌是主要的肿瘤死因。[结论]我国肿瘤登记覆盖范围2010年有明显增加．可以反映不同地区、不同人群的恶性肿瘤负担情况。肿瘤登记为卫生部门提供及时的监测资料,为评估肿瘤负担,评价防治措施和制定肿瘤防治策略方面发挥不可替代的作用。我国目前肿瘤负担严重,应继续加强肿瘤防治工作。     

Annual report on status of cancer in China,2010简

Objective：Population-based cancer registration data in 2010 were collected,evaluated and analyzed by the National Central Cancer Registry （NCCR） of China.Cancer incident new cases and cancer deaths were estimated.Methods：There wvere 219 cancer registries submitted cancer incidence and death data in 2010.All data were checked and evaluated on basis of the criteria of data quality from NCCR.Total 145 registries＇ data were qualified and accepted for cancer statistics in 2010.Pooled data were stratified by urban/rural,area,sex,age group and cancer site.Cancer incident cases and deaths were estimated using age-specific rates and national population.The top ten common cancers in different groups,proportion and cumulative rate were also calculated.Chinese census in 2000 and Segi＇s population were used for age-standardized incidence/ mortality rates.Results：All 145 cancer registries （63 in urban and 82 in rural） covered a total of 158,403,248 population （92,433,739 in urban and 65,969,509 in rural areas）.The estimates of new cancer incident cases and cancer deaths were 3,093,039 and 1,956,622 in 2010,respectively.The morphology verified cases （MV％） accounted for 67.11％ and 2.99％ of incident cases were identified through death certifications only （DCO％） with mortality to incidence ratio （M/I） of 0.61.The crude incidence rate was 235.23/100,000 （268.65/100,000 in males,200.21/100,000 in females）,age-standardized incidence rates by Chinese standard population （ASIRC,2000） and by world standard population （ASIRW） were 184.58/100,000 and 181.49/100,000 with the cumulative incidence rate （0-74 years old） of 21.l 1％.The cancer incidence and ASIRC were 256.41/100,000 and 187.53/100,000 in urban areas whereas in rural areas,they were 213.71/100,000 and 181.10/100,000,respectively.The crude cancer mortality in China was 148.81/100,000 （186.37/100,000 in males and 109.42/100,000 in females）,age-standardized incidence rates by Chinese standard population （ASMRC,2000） and by world standard population （ASMRW） were 113.92/100,000 and 112.86/100,000,and the cumulative incidence rate （0-74 years old） was 12.78％.The cancer mortality and ASMRC were 156.14/100,000 and 109.21/100,000 in urban areas,whereas in rural areas,they were 141.35/100,000 and 119.00/100,000 respectively.Lung cancer,gastric cancer,colorectal cancer,liver cancer,esophageal cancer,pancreas cancer,encephaloma,lymphoma,female breast cancer and cervical cancer,were the most common cancers,accounting for 75％ of all cancer cases in urban and rural areas.Lung cancer,gastric cancer,liver cancer,esophageal cancer,colorectal cancer,pancreatic cancer,breast cancer,encephaloma,leukemia and lymphoma accounted for 80％ of all cancer deaths.Conclusions：The coverage of cancer registration population had a rapid increase and could reflect cancer burden in each area and population.As the basis of cancer control program,cancer registry plays an irreplaceable role in cancer epidemic surveillance,evaluation of cancer control programs and making anticancer strategy.China is facing serious cancer burden and prevention and control should be enhanced.     

2013年湖北省肿瘤登记地区恶性肿瘤发病与死亡分析

目的 分析2013年湖北省肿瘤登记地区恶性肿瘤的发病与死亡情况。方法 收集2013年湖北省9个肿瘤登记处上报的恶性肿瘤发病与死亡数据以及人口资料,并用相关工具对数据进行审核与质量评估。各项质量评价指标均按国家标准纳入。结果 2013年,湖北省9个肿瘤登记地区新发病例数29 738例,发病率为284.85/10万,中标率为188.08/10万,世标率为203.59/10万。肺癌、消化系统肿瘤乳腺癌的发病率和死亡率均居前列。2013年,湖北省肿瘤登记地区恶性肿瘤死亡病例数17 986例,死亡率172.28/10万,中标率和世标率分别为107.97/10万和122.54/10万。男性发病率与死亡率均高于女性,城市地区发病率与死亡率均高于农村地区。结论 2013年湖北省肿瘤登记地区恶性肿瘤发病中标率较2012年略下降,死亡率略低于全国水平。肺癌、消化系统恶性肿瘤（肝癌、胃癌、食管癌、结直肠癌）以及乳腺癌是湖北省肿瘤防治工作的重点癌种,需重点针对这些癌种加强居民防癌核心知识的健康教育。     

Nasopharyngeal carcinoma incidence and mortality in China in 2009

Nasopharyngeal carcinoma (NPC) is rare global y but common in China and exhibits a distinct ethnic and geographic distribution. In 2009, the National Central Cancer Registry in China provided real-time...     

2014年广西肿瘤登记地区结直肠肛门癌发病和死亡分析

目的  分析2014年广西结直肠肛门癌发病和死亡情况。方法  按照全国肿瘤登记中心制定的审核方法和评价标准评估广西肿瘤登记地区上报的2014年肿瘤登记数据,将9个入选的肿瘤登记地区的肿瘤发病、死亡和人口数据进行汇总,按地区（城乡）、性别、年龄别分层,计算结直肠肛门癌的发病率、死亡率、构成比和截缩率等。人口标准化率根据2000年全国人口普查结构和Segis′s世界人口结构。结果  2014年广西纳入分析的9个肿瘤登记地区结直肠肛门癌新发病例为1 716例（其中男性1 039例,女性677例）,发病率为24.74/10万,中标率为19.68 /10万,世标率为19.37/10万,男性发病率高于女性（28.73% vs 20.40%,χ²=48.433,P<0.001）;城市地区发病率为36.19/10万,中标率为27.45/10万;农村地区发病率为19.24/10万,中标率为16.07/10万。结直肠肛门癌死亡病例827例（其中男性518例,女性309例）,死亡率为11.93/10万,中标率为9.06/10万,世标率为9.00 /10万,男性死亡率高于女性（14.32% vs 9.31%,χ²=36.400,P<0.001）;城市地区死亡率为17.63/10万,中标率为13.21/10万;农村地区死亡率为9.18/10万,中标率为7.13/10万。结论  广西肿瘤登记地区结直肠肛门癌发病和死亡例数男性均高于女性,城市地区高于农村地区,45岁以上的中老年人群尤其是城市地区男性人群是重点开展肿瘤防治工作的对象。     

2013年河北省石家庄市恶性肿瘤发病和死亡分析

[目的]分析2013年石家庄肿瘤登记地区恶性肿瘤的发病和死亡情况.[方法]按照全国肿瘤登记中心制定的审核方法和评价标准,对石家庄肿瘤登记处报告的2013年肿瘤登记数据进行评估,按性别、年龄、肿瘤部位分别计算恶性肿瘤的发病率、死亡率、前10位恶性肿瘤顺位和构成.采用2000年中国标准人口构成和Segi's世界人口构成为标准计算标化率.[结果] 2013年石家庄肿瘤登记地区为市内五区城市人群,覆盖人口为2 155 391人.恶性肿瘤新发病例5002例,死亡病例2803例.发病率为232.07/10万(男性258.22/10万,女性206.64/10万),中标发病率为157.03/10万,世标发病率为154.14/10万,累积率(0～74岁)为18.18％.死亡率为130.05/10万(男性164.87/10万,女性96.18/10万),中标死亡率为80.08/10万,世标死亡率为79.24/10万,累积率(0～74岁)为8.78％.肺癌、胃癌、乳腺癌、肝癌、结直肠癌是石家庄市的主要恶性肿瘤,占全部新发病例的57.30％.主要的恶性肿瘤死因是肺癌、肝癌、胃癌、食管癌、结直肠癌,占全部恶性肿瘤死亡病例的67.89％.[结论]石家庄市城市居民发病和死亡居首位的均是肺癌,应将其作为重点防治的癌种.男性恶性肿瘤的发病率与死亡率均高于女性,应对重点人群采取一定的干预措施.     

Estimates of cancer incidence and mortality in China, 2013

Introduction:Population-based cancer registration data are collected by the National Central Cancer Registry in China every year.Cancer incident cases and cancer deaths in 2013 were analyzed.Methods:Through the procedure of quality control,reported data from 255 registries were accepted to establish the national database for cancer estimates.Incidences and mortalities were calculated with stratification by area (urban/ rural),sex (male/female),age group (0,1-4,5-9,10-14...80-84,and 85-year-old and above),and cancer site.The structure of Segi's population was used for the calculation of age-standardized rates (ASR).Top 10 most common cancers and leading causes of cancer deaths were listed.Results:In 2013,3,682,200 new cancer cases and 2,229,300 cancer deaths were estimated in China based on the pooled data from 255 cancer registries,covering 16.6S％ of the national population.The incidence was 270.59/100,000,with an ASR of 186.15/100,000;the mortality was 166.83/100,000,with an ASR of 108.94/100,000.The top 10 most common cancer sites were the lung,stomach,liver,colorectum,female breast,esophagus,thyroid,cervix,brain,and pancreas.The ten leading causes of cancer deaths were lung cancer,liver cancer,gastric cancer,esophageal cancer,colorectal cancer,pancreatic cancer,female breast cancer,brain tumor,leukemia,and lymphoma.Conclusions:Cancer leaves serious disease burden in China with high incidence and mortality.Lung cancer was the most common cancer and the leading cause of cancer death in China.Efficient control strategy is needed,especially for major cancers.     

2015年中国子宫体癌发病与死亡分析

目的根据中国各省市登记处上报的2015年肿瘤登记数据,估算2015年中国子宫体癌发病与死亡情况。方法收集整理中国501个登记处上报的2015年肿瘤登记数据,对数据进行质量审核和评估,将符合标准的368个登记处数据纳入分析,按地区(城市、农村、东部、中部和西部)和年龄等因素分层,计算子宫体癌的发病率和死亡率,结合2015年全国人口数据估算全国子宫体癌发病和死亡数据。标化率分别采用2000年全国普查人口和Segi′s世界标准人口计算。结果2015年纳入分析的368个登记处覆盖309553499人口,占全国2015年年末人口的22.52%。估计全国子宫体癌新发病例数约6.89万,发病率为10.28/10万,中标率为6.86/10万,世标率为6.66/10万。城市地区发病率(11.35/10万)高于农村地区(8.90/10万),东部地区发病率(12.12/10万)高于中部地区(9.94/10万)和西部地区(8.25/10万)。估计2015年全国因子宫体癌死亡病例数约1.60万,死亡率为2.39/10万,中标率为1.49/10万,世标率为1.47/10万。城市地区死亡率(2.40/10万)与农村地区(2.39/10万)相似;中部地区死亡率(2.55/10万)高于东部地区(2.32/10万)和西部地区(2.31/10万)。结论中国子宫体癌发病不断上升且有年轻化趋势,威胁女性健康,疾病负担逐渐加重。中国子宫体癌发病存在城乡和区域差异,应有针对性地开展防控工作。     

2016年山西省肿瘤登记地区肝癌发病与死亡分析

目的 分析2016年山西省肿瘤登记地区居民肝癌发病、死亡情况,为制订肝癌防治策略提供依据。方法 收集山西省12个肿瘤登记地区居民肝癌发病和死亡资料,统计肝癌发病率、死亡率等指标,分别采用2000年中国标准人口年龄构成和Segi's世界标准人口年龄构成计算中标率和世标率,分析不同性别、年龄、以及城乡居民肝癌发病率和死亡率。结果 2016年山西省肿瘤登记地区肝癌新发病例754例,发病率为15.42/10万（男性19.40/10万,女性11.29/10万）,中标率和世标率分别为10.72/10万、10.75/10万;城市地区发病率为10.14/10万,中标率为6.73/10万;农村地区发病率为19.00/10万,中标率为13.48/10万。山西省肿瘤登记地区肝癌死亡病例761例,死亡率为15.56/10万（男性19.80/10万,女性11.17/10万）,中标率和世标率分别为10.71/10万、10.86/10万。城市地区死亡率14.90/10万,中标率为9.86/10万,农村地区死亡率为16.01/10万,中标率为11.37/10万。肝癌发病率和死亡率均随年龄增加呈上升趋势,35岁以后发病率上升较为明显,全省发病率和死亡率分别在80岁和85岁年龄组达到高峰,男性高于女性。结论 山西省肿瘤登记地区肝癌发病率和死亡率均低于全国平均水平,男性发病率高于女性,农村地区发病率高于城市地区,应将男性及农村地区人群作为肝癌防治的重点对象。     

Pancreatic cancer incidence and mortality patterns in China, 2011

Objective

The National Central Cancer Registry (NCCR) collected population-based cancer registration data in 2011 from all cancer registries in China. The incidence and mortality rates for pancreatic cancer were compiled and pancreatic cancer incident new cases and deaths were estimated.

Methods

A total of 234 cancer registries submitted cancer data to NCCR. Data from 177 cancer registries were qualified and compiled for cancer statistics in 2011. Pancreatic cancer cases were extracted and analyzed from the national database. The pooled data were stratified by area (urban/rural), gender and age group (0, 1-4, 5-9, 10-14…85+). Pancreatic cancer incident cases and deaths were estimated using age-specific rates and national population in 2010. The national census in 2000 and Segi’s population were used for age-standardized rates.

Results

All 177 cancer registries (77 in urban and 100 in rural areas) covered 175,310,169 populations (98,341,507 in urban and 76,968,662 in rural areas). The morphology verified pancreatic cancer cases (MV%) accounting for 40.52% and 4.33% of pancreatic cancer incident cases were identified through death certifications only (DCO%) with mortality to incidence ratio (M/I) of 0.91. The estimated number of newly diagnosed pancreatic cancer cases and deaths were 80,344 and 72,723 in 2011, respectively. The crude incidence rate was 5.96/100,000 (males 6.57/100,000, females 5.32/100,000). The age-standardized incidence rates by Chinese standard population (ASIRC) and by world standard population (ASIRW) were 4.27/100,000 and 4.23/100,000 respectively, ranking 10^th among all cancers. Pancreatic cancer incidence rate and ASIRC were 7.03/100,000 and 4.94/100,000 in urban areas whereas they were 4.84/100,000 and 3.56/100,000 in rural areas. The incidence rate of pancreatic cancer of 33 cancer registries increased from 3.24/100,000 in 2003 to 3.59/100,000 in 2011 with an annual percentage change (APC) of 1.44. The pancreatic cancer mortality rate was 5.40/100,000 (males 5.88/100,000, females 4.89/100,000), ranking 6^th among all cancers. The age-standardized mortality rates by Chinese standard population (ASMRC) and by world standard population (ASMRW) were 3.81/100 000 and 3.79/100 000. The pancreatic cancer mortality and ASMRC were 6.47/100,000 and 4.48/100,000 in urban areas, and 4.27/100,000 and 3.08/100,000 in rural areas, respectively. The mortality rates of pancreatic cancer showed an approximately 1.14-fold increase, from 2.85/100,000 in 2003 to 3.26/100,000 in 2011, with an APC of 1.68.

Conclusions

The burden of pancreatic cancer is increasing in China. Identification of high-risk population and adequate treatment and prevention are important.